<DOC>
	<DOCNO>NCT00595504</DOCNO>
	<brief_summary>This study involve people schizophrenia schizoaffective disorder currently take antipsychotic medication . Some antipsychotic medication may cause weight gain may increase risk diabetes mellitus heart disease.The purpose study find happen another medication ( ramelteon ) use along antipsychotic medication . We want find whether : - Change way body break fat sugar . - Affect waist size , stomach fat triglyceride ( type fat blood ) . - Improve body respond insulin . - Affect quality sleep . - Reduce movement disturbance Ramelteon approve U.S. Food Drug Administration ( FDA ) treat people difficulty fall asleep . It approve thing affect waist size improve body break fat sugar . Its use study investigational .</brief_summary>
	<brief_title>Ramelteon Adjunct Therapy Non-Diabetic Patients With Schizophrenia</brief_title>
	<detailed_description>This 8-week randomized , double blind , placebo-controlled pilot study 4- week follow assessment , ramelteon 8 mg/day , administer subject 8 consecutive week adjunctive therapy 40 non-diabetic schizophrenia subject examine ramelteon effect body composition , glucose lipid metabolism , sleep quality symptom tardive dyskinesia use Massachusetts General Hospital General Clinical Research Center . As far know , previous study do explore potential role ramelteon improve metabolic , sleep , movement disturbance schizophrenia subject . The novel approach adjunctive ramelteon treatment schizophrenia population promising .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<criteria>diagnosis schizophrenia , schizoaffective disorder , subtype schizophreniform disorder male female , age 1865 year treatment clozapine , olanzapine , quetiapine risperidone well establish compliance medication Body Mass Index ( BMI ) &gt; 27 Kg/m² component metabolic syndrome insulin resistance BMI &gt; 30 Kg/m² : inability provide inform consent substance alcohol abuse significant medical illness , include congestive heart failure , severe hepatic impairment , severe Chronic Obstructive Pulmonary Disease ( COPD ) , severe sleep apnea , severe cardiovascular disease renal disease current history diabetes mellitus thyroid disease woman pregnant , breastfeeding , unwilling unable use effective form birth control entire study psychiatrically unstable , patient major depression patient treated medication know affect glucose tolerance birth control pills contain norgestrel , steroid , beta blocker , antiinflammatory drug ( include daily aspirin ibuprofen ) , thiazide diuretic ; agent induce weight loss exclude study treatment fluvoxamine ketoconazole past two week treatment fluconazole ( strong CYP2C9 inhibitor ) . subject treat ziprasidone aripiprazole conventional agent treatment sedativehypnotics barbiturate , zolpidem , eszopiclone , zaleplon . The use stable daily dos benzodiazepine allow . know hypersensitivity ramelteon component</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>metabolism</keyword>
	<keyword>antipsychotic</keyword>
	<keyword>diabetes</keyword>
	<keyword>rozerem</keyword>
</DOC>